Centro Oncologico Riojano Integral ( Site 1101)
La Rioja F5300COE
0 studies enrolling now · 1 studies all time
What they study most
Renal Cell Carcinoma
Studies at this site
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
— Completed